Study Design: Retrospective analysis. Level of evidence III.
Introduction
Low-energy vertebral compression fractures (VCFs) represent a significant cause of morbidity among elderly patients. Percutaneous vertebroplasty (PV) is an effective and well-recognized treatment for VCF. 1, 2 This procedure is considered the first line of treatment for osteoporotic fractures when conservative treatment has failed. [2] [3] [4] [5] Although PV is a relatively safe procedure, complications such as cement leakage, cord compression, nerve root damage, infection, and new VCF have been described. [6] [7] [8] The frequency of new VCF varied, ranging from 8% to 52%, [8] [9] [10] [11] and most of these reported fractures occurred at adjacent levels. 2, 10 In the literature, it is well recognized that aspects related to patients, such as low bone mineral density and low body mass index (BMI), as well as other technical factors such as vertebral height restoration, are associated with new VCF. [11] [12] [13] [14] [15] [16] Other variables such as presence of intradiscal cement leakage, relative amount of cement (measured as cement percentage), or postprocedure initial vertebral kyphosis are not clearly established.
The objective of our study was to evaluate epidemiological and technical variables in patients who suffered a new VCF requiring a new PV in comparison with a control group. 
Material and Methods
The study protocol was approved by the ethics review board of Hospital Italiano de Buenos Aires (Approval Number IRB00010193) and in concordance with the Declaration of Helsinki.
We designed a case-control study nested in a cohort of consecutive adult patients who underwent PV for low-energy fractures between April 2008 and November 2014 at the Hospital Italiano de Buenos Aires, a tertiary university hospital. Inclusion criterion was the following: PV after low-energy VCF at 1 level (Figure 1) , with a minimum 1-year follow-up. Exclusion criteria were the following: more than 1-level vertebroplasty, metastasis, previous spine surgery, hemangiomas, and less than 12-month follow-up ( Figure 2) .
The study group included 30 consecutive patients having new VCF that required another vertebroplasty during the first year after the procedure, and the new VCF was classified as adjacent (superior or inferior to the treated level) and nonadjacent (at least 1 level spared between the original vertebroplasty and the new VCF). As a control group, we selected 60 patients (2:1 ratio) matched for age (+ 5 years) and level (thoracic, lumbar).
Baseline characteristics (sex, age), comorbidities, BMI, osteoporosis (defined as less than 2.5 densitometry), level of vertebroplasty, initial vertebral kyphosis, as well as technical measurements such as percentage of cement filling in the fractured vertebra and cement leakage to the superior or inferior disk space were also collected in a standardized form by retrospective review of the clinical chart. Before the procedure, all patients were studied with standing X-rays and magnetic resonance imaging (MRI; Achieva, Phillips, Netherlands). Vertebroplasty was performed in an angiography suite with cone-beam computed tomography (Artis Zeego, Siemens, Germany). The measurement of vertebral kyphosis was performed by Surgimap 2.2.8 on lateral X-rays with the patient in standing position; superior and inferior end plates of the fractured vertebra were measured. Measurement of percentage of cement and volume in the fractured vertebras as well as cement leakage to the superior or inferior disk spaces were assessed with Vitrea Advance workstation (Vital Images, Toshiba Medical, MN). Volume calculation was performed by taking the vertebral perimeter on an axial plane from the superior endplate ( Figure 3A ) up to the inferior endplate to calculate the exact percentage and volume of the intravertebral cement ( Figure  3B-D) ; the software generates a surface using the height of the vertebra and cement in order to assess a volume.
A total of 542 patients underwent PV between 2008 and 2014. Among them, 153 patients (28%) with spinal metastasis and 9 patients (1.6%) with aggressive hemangiomas were excluded; 380 patients (70%) with osteoporotic vertebral fractures were further evaluated; 215 patients were excluded because of compromise at more than 1 level, 35 patients were excluded for having spinal instrumentation, and 27 patients were lost to follow-up ( Figure 2 ). Finally, the study population consisted of 103 patients, 30 experienced a new VCF and 73 without a new VCF; in order to make the match ratio 2:1, 13 patients were randomly removed from the control group. Thus, 452 patients (83%) were excluded.
Bisphosphonates and calcium-rich diet were the main medical intervention, 1 patient from group 1 and 2 patients from group 2 developed osteoporosis secondary to chronic corticoids therapy.
Vertebroplasty Technique
Percutaneous vertebroplasty was performed in an angiographic suite. All procedures were done under general anesthesia. One 11-gauge bone needle was advanced through a transpedicular or costovertebral approach. The needle tip was placed in the anterior third of the vertebral body under anteroposterior and lateral fluoroscopy. Methylmethacrylate was mixed in five 1-mL syringes. Under biplane fluoroscopic guidance, the cement was injected by using the syringes. We injected bone cement (polymethylmethacrylate) and stopped when the cement reached the posterior third of the vertebral body or when any leakage occurred.
Statistical Analysis
Numerical variables were described as means with standard deviation or median and interquartile range according to distribution, and categorical variables were described as absolute frequencies and percentage. Univariate analysis was performed using conditional logistic regression to assess association with new fracture after vertebroplasty. Confounders were adjusted using the multivariate conditional regression logistic model. Candidates' variables for the multivariate model were osteoporosis, initial vertebral kyphosis, percentage of cement, and cement volume injected. The search for the best model was based on clinical and statistical significance. A P value less than .05 was considered statistically significant. The analysis was performed using STATA version 13 (College Station, TX).
Results
Thirty patients experienced a new VCF within the first year after PV. The incidence of new VCF after PV was 8.5% (95% confidence interval ¼ 6.4% to 10.9%).
Among the 90 patients (cases and controls), females represented 81% (73), and the mean age was 76 years (74.8 in group 1 and 76.3 in group 2). Table 1 shows the description of the patients who experienced a new vertebral fracture after PV (case group). Table 2 describes baseline characteristics in both groups (cases and controls).
Baseline Characteristics
Factors Associated With New Symptomatic VCF After PV Table 3 shows factors studied in relation to new symptomatic VCF after PV.
Among the factors, age, female sex, osteoporosis, and BMI were found to have no statistical difference between groups (P > .05). However, we noticed a tendency for new VCF in women with osteoporosis, elderly patient, and high BMI.
Regarding osteoporosis, we found no differences in terms of medical treatment modalities in both groups.
In relation with technical factors, there was no significant difference when comparing disk cement leakage between groups (P ¼ .46).
Vertebral cement percentage and initial vertebral kyphosis were factors in which we found statistically significant difference. The mean percentage of cement filling was 40.3% in the case group versus 30.6% in the control group (P ¼ .01), and the initial vertebral kyphosis was 14.9 versus 9.2 (P ¼ .01). 
Adjacent and Nonadjacent New VCF in the Study Group
In the study group, from a total of 30 new fractures, 11 were adjacent at the level from the PV (37%). When comparing baseline and technical features in this subgroup with the nonadjacent group, there was no significant difference. However, the percentage of women was higher in adjacent VCF and the time of new vertebral fracture was sooner. In addition, vertebral cement percentage was higher in adjacent VCF, although no significant differences were observed between these 2 subgroups (Table 4) .
Discussion
Percutaneous vertebroplasty is a safe and effective therapeutic option for the treatment of painful VCF when medical treatment is not effective; however, some complications have been described such as new vertebral fracture at another level. [5] [6] [7] This study evaluates factors associated with new symptomatic VCF after PV, including BMI, osteoporosis, age, and sex distribution, as well as procedure-related factors such as vertebral cement percentage, disk cement leakage, and vertebral kyphosis. In this series from our institution, the incidence of new VCF was 8.5% after 1-year follow-up, lower than those reported by Anselmetti et al 2 in a multicenter study (EVEREST group) with 13% of new vertebral fracture. Voormolen et al 12 and Lin et al 13 reported a higher incidence of new VCF of 24% and 30%, respectively. Although the evidence of new VCF varies from 8% to 52%, [8] [9] [10] [11] our results could be explained by the study design. Our incidence might be lower due to the inclusion of only symptomatic fractures with new vertebroplasty requirement and no active screening.
Our findings show that factors associated with new VCF at bivariate analysis were age, vertebral cement percentage, and degrees of initial vertebral kyphosis. Previous studies have analyzed factors related to increased risk of new vertebral fracture. Ma et al, 14 in a systematic review, observed 3 strong factors associated with VCF after PV (lower bone mineral density, vertebral height restoration, and intradiscal cement leakage) and 6 moderate-evidence factors such as lower BMI, number of preexisting vertebral fractures, thoracolumbar junction, cement distribution, older age, and number of treated vertebrae. Osteoporosis and low BMI are known major factors associated with increased risk of vertebral fractures. [14] [15] [16] In our study, however, osteoporosis, BMI, and sex distribution showed no differences between the new vertebral fracture group and the control group. Regarding osteoporosis, we observed a higher prevalence in the study group compared with the control group, without significant differences, and we also evaluated the medical treatment and found no differences in terms of therapeutic algorithm in both groups.
Concerning procedure-related factors, the amount of cement injected was considered presumably associated with adjacent fracture 9, 17, 18 ; however, there are no specific algorithms with regard to the most appropriate cement fraction required to restore stiffness without increasing the risk of cement leakage and new VCF. Nieuwenhuijse et al 19 analyzed the vertebral cement body fraction required to reduce pain after vertebral osteoporotic fractures and found an optimal fraction of 24% of the vertebral body. Liebschner et al, 20 in an experimental study, found that restoration of stiffness was reached with 15% of vertebral cement volume and use of a 30% fill increased stiffness by more than 50% compared with the predamaged value.
The difference between cemented vertebra and adjacent osteoporotic level creates pulling forces that increase the risk of new vertebral fracture 17, 18 associated with patients' increased activity secondary to pain relief that may create a mechanical stress. 9 Luo et al 21 in a biomechanical study found that 3.5 mL were required to restore normal stress distribution after VCF. However, other authors 9 suggested that a fractured vertebra should be filled as much as possible. In our study, vertebral cement percentage was significantly higher in the new VCF group compared with the control group. These results can be explained by increased stiffness of the cemented vertebra.
Initial vertebral kyphosis after fracture could increase the risk of new fracture because of spinal imbalance, especially at the thoracolumbar junction. 17, 18 In addition, kyphosis restoration was also found to be a risk factor for new fracture. 22 In our study, significantly higher vertebral kyphosis in the new fracture group compared with the control group was found; however, kyphosis restoration was not evaluated in our study. Fifty-one percent of fractures occurred at the thoracolumbar junction; however, thoracolumbar junction was not associated with risk of new VCF in the present study.
Cement migration to the disk space with consequent stiffness increment has been associated with new VCF. 8 Results of multivariate analysis suggest that the risk of new VCF is 4.6 times higher in patients with cement leakage than in patients free of leakage. 11 In our study, cement leakage into the disk space was higher in the study group compared with the control group (30% and 21%, respectively); however, no significant differences were found. Similar results were observed by Lin et al, who reported 21% of cement leakage in the new VCF group compared with 22% in the non-new VCF group. 13 The lack of statistical significance in factors associated with new symptomatic VCF after PV could be explained by the small number of patients. Additionally, difference from previous studies could be due to patients' detection method (limited case detection), including types of events (symptomatic VCF).
Regarding adjacent and nonadjacent VCF, it is accepted that adjacent osteoporotic VCF is more common than nonadjacent VCF after PV and usually within the first month.
9,10,23 Takahara et al 22 found increasing age and low BMI as risk factors of adjacent VCF in osteoporotic postmenopausal women. In our study, the number of adjacent VCF 12 and nonadjacent VCF 20 were similar; adjacent VCF occurred sooner than nonadjacent VCF, but without significant differences. Anselmetti et al, 2 in a multicenter study, observed that 80% of new VCF occurred adjacent to the vertebroplasty. Analyzing epidemiological risk factors, we observed a tendency of adjacent VCF to occur in older females with low BMI, but without significant differences. Our study has strengths. First, one spinal fellow who does not perform the procedures made analysis; electronic medical records allow specific clinical and interventional data. This means that the data collection process is reliable as it collects information in a systematic and rigorous manner, with a standardized process. Second, Hospital Italiano receives patients who are representative of the Buenos Aires population. In addition, we would like to highlight limitations including retrospective data re-collection. Additionally, the population with only symptomatic VCF were included, which could underestimate the real number of new VCFs. There are strong factors associated with new VCF; however, no thoroughly evidence-based recommendation exists with regard to procedure-related factors, such as the exact amount of cement required to relieve pain and not to increase the rate of new VCF. More evidence is required to establish a proper technical algorithm in vertebroplasty.
Conclusion
In summary, in our study, 8.5% of the patients analyzed had new vertebral fractures that required new PV, and the most important factors associated with new VCF after vertebroplasty were vertebral cement percentage and initial vertebral kyphosis, and both factors were statistically significant in the new vertebral fracture group. These aspects should be considered in order to decrease the rate of new VCF.
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